3rd International Conference on Influenza and Emerging Infectious Diseases April 10-11, 2019 Toronto, Ontario, Canada

Dr Taha Nazir has multiple expertise with advanced knowledge of microbiology, pharmacology, and molecular biology. Dr Nazir has more than twenty year’s research, academic and professional experience. Additionally, his research interest includes the drug designing, novel formulations, cell pathology, epidemiologies, and biotechnology. Moreover, Dr Nazir has worked at prestigious research, academic and professional including Associate Professor, Associate Dean (Pharmaceutical Sciences), Chairman Board of Directors and President (Pharmacist Federation). He has worked with ICDTD Inc., Saskatoon SK, Drug Store Pharmacy Calgary AB, Medicine Shoppe Pharmacy Saskatoon SK, and the University of Lahore and the University of Sargodha. Currently, Dr Nazir is associated with ICDTD Inc. Canada as Head - Microbiology, Chemical Pathology and Molecular Biology Research Group, ICDTD Inc., Canada. Moreover, he performs a variety of role to develop partnerships between academic and practical skills. He has compiled six different books entitled Applied Pharmacotherapy, Applied Molecular Cell Biology, Clinical and Pharmaceutical Management of Diseases and Practical Manual of Pharmacology & Therapeutics. Dr. Nazir has authored more than 30 research articles published in reputed and accredited scientific journals.

Public Health Microbiology Human Microbiota Antimicrobial Resistance Meta-genomics & Bioinformatic Tools Microbial Resource Management Applied Microbiology Food Microbiology Diversity of Microbes and Viruses

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research

Murine Virology, Antiviral Chemotherapy,Vaccines, Effects of inhibitors on viraI replication,Studies on the role of herpesviruses in cancer, Tumor immunology,Pathology of AIDS

Dr. Theresa I. Dale, Ph.D., CCN, NP Founder & Dean, California College of Natural Medicine, Ventura, CA. President & CEO, The Wellness Center for Research & Education, Inc. Author * Inventor * Researcher * Biological Medical Consultant Dr. Dale’s interest in non-invasive therapies became her passion when she was diagnosed with a uterine tumor at 22 years of age. After healing herself of the tumor by herself in six months using only natural medicine, she decided to make natural medicine her career. She completed her Naturopathic Studies in Europe. In 1992 Dr. Dale founded The Wellness Center for Research and Education, Inc. The California College of Natural Medicine (501C3) was then founded to train health providers in advanced Biological Medicine. A Winning Combination! Dr. Dale is the “Pioneer of Hormone Rejuvenation” with over 20,000 case studies using her advanced formulas NuFem & EndoPure for Men and Women and her “Five Element Salivary Test” panel with her custom Wellness ProgramMoreover, Dr. Dale’s organic herbal and clean nutritional formulas have been proven successful in clinical testing. Furthermore, Advanced Homeopathic research lead to her formulation of the first Fibonacci Sequenced Homeopathic product line. She offers lectures and workshops to medical professionals and speaks at various conferences. Dr. Dale has authored two books “Revitalize Your Hormones; Dr. Dale’s 7 Steps to a Happier, Healthier and Sexier You” and "Transform Your Emotional DNA, Understanding the Blueprint of Your Life”.

non-invasive therapies

Dr. Ananda M. Chakrabarty serves as Senior Science Advisor of Amrita Therapeutics Limited. Dr. Chakrabarty is a Amrita’s Senior Science Mentor and Global Domain Expert relating to how bacterial proteins effectively combat cancers, parasites, and viruses in the human body. Dr. Chakrabarty serves as a Distinguished University Professor of Microbiology and Immunology at the University of Illinois College of Medicine, and advises senior officials in the U.S. and abroad on policies relating to biotechnology and related technology transfer. He is a Consultant to the United Nations. In 1980, Dr. Chakrabarty’s genetically modified Pseudomonas bacteria became the first genetically-engineered organism to gain a patent, as a result of the Supreme Court decision in Diamond vs. Chakrabarty. Dr. Chakrabarty undertook pioneering biotechnology research into the therapeutic potential for protein products of bacteria, both at the University of Illinois at Chicago (UIC) and on behalf of CDG Therapeutics, a U.S. biotechnology start-up company engaged in clinical cancer research. Dr. Chakrabarty has led path-breaking research into the therapeutic qualities of protein products of bacteria. His work includes recent studies with water-soluble products of pathogenic bacteria demonstrating significant promise for cancer therapies, effective against HIV/AIDS, malaria and perhaps even tuberculosis. Dr. Chakrabarty was a part of the Advisory Committee that resulted in creation of the International Center for Genetic Engineering and Biotechnology (ICGEB) in Trieste, Italy and rejoined the ICGEB Advisory Board. Dr. Chakrabarty has numerous publications and has received many notable awards for his contributions to biotechnology, including Padma Shri in 2007, one of the Indian Government’s highest civilian honors.

Cell Biology, Microbiology, Pseudomonas aeruginosa, Cancer Cells, Biotechnology, Oncology, Cancer Biology, Cancer Therapy, Pseudomonas, Malaria, Cystic Fibrosis, Genetic Engineering, Infectious Diseases, Cancer Chemotherapy, Mutation

Dr Helieh Oz has a DVM, MS (U. IL); PhD (U. MN) and clinical translational research certificate (U.KY). Dr Oz is an active member of American Association of Gastroenterology (AGA) and AGA Fellow (AGAF) and associate in Rome Foundation (Functional Gastrointestinal Diseases). Dr Oz is a Microbiologist with expertise in infectious and inflammatory diseases, drugs discovery, pathogenesis, innate/mucosal Immunity, molecular biology, and micronutrient. Dr. Oz has over 90 publications in the areas of chronic inflammatory disorders, microbial and infectious diseases. Dr Oz has served as Lead Editor for special issues including Gut inflammatory, infectious diseases and nutrition 2017 (Mediators of Inflammation); Nutrients, Infectious and Inflammatory Diseases (Nutrients 2017); Gastrointestinal Inflammation and Repair: Role of Microbiome, Infection, Nutrition (Gastroenterology Research Practice 2016), and co-editor for Parasitic infections in pediatric clinical practice (J Pediatric Infectious Disease 2016) and Chagas Disease Book, Intech Open Science 2017. Dr Oz serves as member of different editorial advisory board committees including Center of Excellence for Medical Research and Innovative Products, Walailak University Thailand and is an avid reviewer for several peer-reviewed journals.

Dr. Helieh Oz research interest includes Chronic Inflammatory and Infectious Diseases; Translational Studies, Drug discovery Inflammatory and neuropathic Pain related behavioral modifications. Pathogenesis and Immunomodulation, Mucosal Immunity, Innate Immunity, phagocytosis and pathology; Digestive diseases, Animal models, Carcinogenesis and malignancy, Radiation protection, Inflammatory diseases of gut including IBD, Hepatic and pancreatic inflammatory complications: Cardiovascular disease and Pneumonitis Reactive oxygen radical, micronutrient; antioxidants, Inflammatory Infectious disease, fetal maternal Toxoplasmosis, Chagas disease, P. carinii Pneumonitis and Babesiosis

K M Yacob is a practicing Physician in the field of Healthcare in Kerala, India for the last 29 years. His research interest is spread across fever, inflammation and back pain. He has published nine books and wrote hundreds of articles in various magazines and has scientific studies, and developed 8000 affirmative cross checking questions which can explain all queries related with fever.

Durgesh Sinha, female, did Ph. D (Applied Mathematics), M. Sc. (Mathematics), B. Sc. (Mathematics honors) in 2000, 1996, and 1994 respectively from Vinoba Bhave University, Jharkhand, India. Apart from this she did M. Sc. from Civil and Environmental Engineering department, Temple University, Philadelphia, USA in 2008 to enhance skill on Applied sciences. Since 2008, she started teaching at Temple University (2008), Rowan College at Burlington County (2009), Strayer University (2010), Community College of Philadelphia (2014), and Mercer County Community College (2014) till current as an Adjunct Assistant professor. Meanwhile I involved in research with Dr. Bimal Kumar Mishra (Dean of Student Welfare, BIT Meshra, Ranchi, India) in 2013, and published two papers in reputed Journal Scientific Reports (Nature), and J Immunol. Tech. Infect. Disease in 2016. My current research goal is of Epidemics and cyber-crime.

Epidemics and cyber-crime